Home/Filings/4/0001062993-23-019386
4//SEC Filing

McCourt Janice 4

Accession 0001062993-23-019386

CIK 0001907685other

Filed

Oct 15, 8:00 PM ET

Accepted

Oct 16, 4:59 PM ET

Size

5.6 KB

Accession

0001062993-23-019386

Insider Transaction Report

Form 4
Period: 2023-10-14
McCourt Janice
Chief Business Officer
Transactions
  • Award

    Stock Option (Right to Purchase)

    2023-10-14+20,00020,000 total
    Exercise: $0.29From: 2023-10-14Exp: 2026-10-04Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]On October 4, 2023, the reporting person was granted an option to purchase 20,000 shares of common stock of the issuer. The option vested in full following the satisfaction of certain performance criteria including the execution of a separation agreement and release by the reporting person and the expiration of a seven-day revocation period without the reporting person revoking the separation agreement and release.

Issuer

Comera Life Sciences Holdings, Inc.

CIK 0001907685

Entity typeother

Related Parties

1
  • filerCIK 0001953540

Filing Metadata

Form type
4
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 4:59 PM ET
Size
5.6 KB